Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes

Eye

Volumn 13, Issue 2, 1999, Pages 174-178

  Warpeha, K M ^a   Ah Fat, F ^b   Harding, S ^e   Patterson, C C ^a   Xu, W ^c   Hart, P M ^a   Chakravarthy, U ^d   Hughes, A E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Diabetic retinopathy; EDN1; Genetic susceptibility; NOS3

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE SYNTHASE; PRIMER DNA;

ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DINUCLEOTIDE REPEAT; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE REPEAT; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 0032923082     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1999.46     Document Type: Article

References (25)

1. Cogan DG, Toussaint D, Kuwabarra T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 1961-66:366-78.
2. Poston L, Taylor PD. Endothelium-mediated vascular function in insulin dependent diabetes mellitus. Clin Sci 1995;88:245-55.
3. Stehouwer CDA, Lambert J, Donker AJM, van Hinsberg VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68.
4. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997;350:9-13.
5. Brenner BM, Troy JL, Ballerman BJ. Endothelium-dependent vascular responses: mediators and mechanisms. J Clin Invest 1989;84:1373-8.
6. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelial-dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992;35:771-6.
7. Tesfamariam B, Brown ML, Deykin D, Coehn RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor protanoids in rabbit aorta. J Clin Invest 1990;85:929-32.
8. Ye X, Laties AM, Stone RA. Peptidergic enervation of the retinal vasculature and optic nerve head. Invest Ophthalmol 1990;31:1731-7.
9. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061-70.
10. Clustering of long term complications in families with diabetes in the Diabetes Control & Complications Trial. Diabetes 1997;46:1829-39.
11. Leslie RDG, Pyke DA. Diabetic retinopathy in identical twins. Diabetes 1982;31:19-21.
12. Guillausseau PJ, Tielmans D, Virally-Monod M, Assayag M. Diabetes: from phenotypes to genotypes. Diabetes Metab 1997;23:14-21.
13. Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 1998;47:945-52.
14. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai N, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703-10.
15. Rudic RD, Sheseley EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodelling. J Clin Invest 1998;101:731-6.
16. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
17. Diabetic Retinopathy Study Research Group. A modification of the Airlie House classification of diabetic retinopathy. Diabetic Retinopathy Study Research Group no. 7. Invest Ophthalmol 1981;21:210-6.
18. Pages J-C, Drieu C, Blanche H, Beckmann J, Cann HM. A short tandem repeat polymorphism at the endothelin-1 (EDN1) locus. Hum Mol Genet 1993;2:90.
19. Nadaud S, Bonnardeaux MD, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994;198:1027-33.
20. Bonnardeaux A, Nadaud S, Charru A, Jeunmaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995;91:96-102.
21. Warpeha KM, Ah-Fat F, Harding S, Hart PM, Hughes AE, Chakravarthy U. Polymorphic variability in NOS2 gene may after susceptibility to diabetic retinopathy. Invest Ophthalmol Vis Sci 1998;39:1358.
22. A receptor genes in essential hypertension. J Cardiovasc Pharm 1995;26:S9-12.
23. Chakravarthy U, Hayes RG, Stitt AW, Douglas A. Increased ET1 expression in ocular tissues of diabetic animals. Invest Ophthalmol 1997;38:2144-51.
24. Yanagisawa Y, Yanagisawa M, Kapur R, Richardson J, Williams S, Clouthier D, et al. Dual genetic pathways of endothelin-mediated intercellular signalling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 1998;125:825-36.
25. Brand M, Le Moullec J-M, Corvol P, Gasc J-M. Ontogeny of endothelins-1 and -3: their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest 1998;101:549-59.